[1] |
PENG Peng, YUAN Wei'an, HU Yihui, TANG Jie, JIANG Jian.
Analysis of regulatory issues of adverse events in drug clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 78-82.
|
[2] |
YAN Jianqiang,NIE Gaihong.
Effect of gimeracil capsules combined with radiotherapy on breast cancer and on tumor markers, human epidermal growth factor receptor-2 and midkine levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 899-903.
|
[3] |
LIU Shijia, CHEN Du, YIN Jungang, CHU Jihong, XU Meijuan, LIU Fang, DAI Guoliang, XIONG Ningning, JU Wenzheng.
Comparison of the pharmacokinetics of levetiracetam injection and levetiracetam tablets in human
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 294-298.
|
[4] |
JIANG Yan, ZHANG Fan.
Advances in luminal breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 465-469.
|
[5] |
HU Wen-juan, DENG Xiao-hua, JIN Hui, WU Jian-hui, LIU Xiang-yun, SUN Zu-yue.
Spinal cord deformity effect of cyclophosphamide on fetal
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(4): 380-384.
|
[6] |
ZHOU Yi, SUN Shu-fang, YANG Jun, MIN Qing.
Study of extract of astragalus united epidermal growth factor for the treatment of rat skin burns
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(8): 876-879.
|
[7] |
YUAN Qing-feng, SI Jian-min, ZHOU Wen, ZHANG Xiao, ZHANG Xiao-feng, LV Wen.
Protective effect of epidermal growth factor on the atrophic gastric mucosa in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 136-139.
|
[8] |
LI Jing-jing, FENG Gong-li, ZHU Xiao-feng, ZHANG Xiao-shi.
Synergistic anti-tumor activity of cetuximab combining with cisplatin in human nasopharyngeal carcinoma cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 735-739.
|
[9] |
WU Liang, ZHENG Min-hua.
Clinical progress of anti-epidermal growth factor receptor antibody, cetuximab, in the treatment of colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 837-840.
|
[10] |
HUANG Xiu-rong, QI Ming-xin, HU Yan-hong, YAN Jing, WU Zheng-zheng, MA Lan.
Signal transduction mechanism of inhibition of elemene on proliferation induced by recombinant human epidermal growth factor in lens epithelial cell
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(1): 43-46.
|
[11] |
CHEN Yan, YUAN Shou-jun, LI Zheng-qiang, TIAN Zeng-yue, XU Lan-ping.
A simple method for determining content of nicotine in blood of rats ex-posed in burning cigarette smoke or nicotine fog
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(5): 569-573.
|
[12] |
SHI Hong, LU Yan-ping, QIAN Bo-chu.
Discussion on basic request and standardization in safety pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(9): 961-965.
|
[13] |
WU Nan, WANG Ai-ping, WANG Yin-xiang.
Effects and mechanisms of epidermal growth factor receptor of tyrosine kinase on cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 456-461.
|
[14] |
WU Nan, WANG Ai-Ping.
Immunotoxicology applied in new drug safety assessment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 855-858.
|
[15] |
LI Zhe, YUAN Shou-Jun.
Application of epidermal growth factor receptor tyrosine kinase inhibitors in cancer therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 361-364.
|